37139883|t|[Alpha-2 adrenoreceptor agonists for the intensive care physician].
37139883|a|Clonidine and dexmedetomidine are two alpha2-adrenoreceptors agonists available for the intensivist in the clinical practice. The affinity of dexmedetomidine is eight times greater than clonidine affinity for the alpha2 receptors. Their main effect is sedation. They act by inhibition of noradrenaline release in the locus coeruleus in the brainstem. alpha2-agonists are used primarily for sedation, analgesia, and management of delirium. Nowadays, dexmedetomidine application is increasing in critically ill patients showing a good safety. Most frequent side effects include bradycardia and hypotension.
37139883	1	32	Alpha-2 adrenoreceptor agonists	Chemical	-
37139883	68	77	Clonidine	Chemical	MESH:D003000
37139883	82	97	dexmedetomidine	Chemical	MESH:D020927
37139883	210	225	dexmedetomidine	Chemical	MESH:D020927
37139883	254	263	clonidine	Chemical	MESH:D003000
37139883	356	369	noradrenaline	Chemical	MESH:D009638
37139883	497	505	delirium	Disease	MESH:D003693
37139883	517	532	dexmedetomidine	Chemical	MESH:D020927
37139883	562	576	critically ill	Disease	MESH:D016638
37139883	577	585	patients	Species	9606
37139883	644	655	bradycardia	Disease	MESH:D001919
37139883	660	671	hypotension	Disease	MESH:D007022
37139883	Comparison	MESH:D003000	MESH:D020927
37139883	Negative_Correlation	MESH:D020927	MESH:D016638
37139883	Positive_Correlation	MESH:D020927	MESH:D007022
37139883	Negative_Correlation	MESH:D009638	MESH:D020927
37139883	Positive_Correlation	MESH:D020927	MESH:D001919

